Trial intelligence / Profile preview

Fractionated Proton Radiation Therapy for Vestibular Schwannoma

NCT01199978Phase 2Active, not recruiting

Sponsor
Massachusetts General Hospital
Start
Mar 2011
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of losartan in vestibular schwannoma (VS), sponsored by Massachusetts General Hospital. Started Mar 2011; status: active, not recruiting.

02

Drugs

losartan
03

Conditions

vestibular schwannoma (VS)

Beyond the preview

Go deeper on NCT01199978.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01199978.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call